Molecular interaction of CD1b with lipoglycan antigens

Immunity
W A ErnstR L Modlin

Abstract

The ability of human CD1b molecules to present nonpeptide antigens is suggested by the T cell recognition of microbial lipids and lipoglycans in the presence of CD1b-expressing antigen-presenting cells. We demonstrate the high-affinity interaction of CD1b molecules with the acyl side chains of known T cell antigens, lipoarabinomannan, phosphatidylinositol mannoside, and glucose monomycolate. Furthermore, CD1b-antigen binding was optimal at acidic pH, consistent with the known requirement for endosomal acidification in CD1b-restricted antigen presentation. The mechanism for CD1b-ligand interaction involves the partial unfolding of the alpha helices of CD1b at acidic pH, revealing a hydrophobic binding site that could accommodate lipid. These data provide direct evidence that the CD1b molecule has evolved unique biochemical properties that enable the binding of lipid-containing antigens from intracellular pathogens.

References

Aug 1, 1992·International Immunology·J M LeeT H Watts
Dec 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·M R JacksonP A Peterson
Jan 1, 1991·Tissue Antigens·F Calabi, A Bradbury
Dec 1, 1987·The Journal of Cell Biology·D J Yamashiro, F R Maxfield
Sep 24, 1985·Biochemistry·K C Parker, J L Strominger
Jul 1, 1984·Cell·I A WilsonR A Lerner
Jan 1, 1995·Advances in Immunology·S A Porcelli
Jul 14, 1995·Science·P A SielingP J Brennan
Dec 20, 1994·Proceedings of the National Academy of Sciences of the United States of America·K MatsuiM M Davis
Aug 30, 1994·Proceedings of the National Academy of Sciences of the United States of America·J KapplerP Marrack
Jan 1, 1996·The Journal of Experimental Medicine·H A RunnelsP E Jensen

❮ Previous
Next ❯

Citations

Dec 28, 1999·Journal of Molecular Recognition : JMR·D G Myszka
Sep 15, 2004·Immunogenetics·Fabio CastilloCarlos Parra-López
May 20, 2008·Immunogenetics·Frank A Looringh van BeeckIldiko Van Rhijn
Dec 16, 2000·Springer Seminars in Immunopathology·C T MoritaM B Brenner
Oct 14, 2003·Microbes and Infection·Carme Roura-Mir, D Branch Moody
Aug 26, 1998·Immunology Today·S A PorcelliM B Brenner
Jul 25, 2003·Human Immunology·Yuzhi DongYuri Bushkin
Jan 13, 2001·Current Opinion in Immunology·J L Matsuda, M Kronenberg
Jan 13, 2001·Current Opinion in Immunology·J Jayawardena-Wolf, A Bendelac
Dec 24, 2002·Current Opinion in Immunology·Sebastian Joyce, Luc Van Kaer
Feb 27, 1999·Current Opinion in Immunology·V M BraudA J McMichael
Sep 16, 2000·Trends in Microbiology·U E Schaible, S H Kaufmann
Dec 10, 1998·Trends in Microbiology·T I Prigozy, M Kronenberg
Dec 28, 1999·Microbes and Infection·G R Strohmeier, M J Fenton
Dec 21, 2002·Tissue Antigens·Y Dutronc, S A Porcelli
Jul 23, 2013·Nature Immunology·Stefano VavassoriGennaro De Libero
Jul 21, 2006·Nature Immunology·D Branch Moody
May 3, 2005·Nature Reviews. Immunology·D Branch MoodyIan A Wilson
Jun 2, 2005·Nature Reviews. Immunology·Gennaro De Libero, Lucia Mori
May 8, 1999·Immunology·D M HaigH R Miller
Nov 28, 2001·Immunology·D B Moody, G S Besra
Jul 27, 2011·Proceedings of the National Academy of Sciences of the United States of America·Luis F Garcia-AllesHenri de la Salle
Feb 6, 2010·The Journal of Biological Chemistry·Artur N OdyniecMichael B Brenner
Aug 24, 2011·The Journal of Biological Chemistry·Jordi B TorrellesLarry S Schlesinger
Jan 5, 1999·The Journal of Experimental Medicine·E P GrantM B Brenner
Oct 19, 1999·The Journal of Experimental Medicine·O V NaidenkoM Kronenberg
Jan 8, 2003·The Journal of Experimental Medicine·Ludovic TailleuxOlivier Neyrolles
Feb 16, 2002·The EMBO Journal·V BrikenS A Porcelli
Jun 10, 2004·Immunology and Cell Biology·Anna P Lawton, Mitchell Kronenberg
Jul 10, 1999·Immunological Reviews·F M BrodskyE M Bennett
Jan 13, 2000·Immunological Reviews·D B MoodyS A Porcelli
Jun 18, 2002·Infection and Immunity·Claudia BrodskynManoel Barral-Netto
Jun 8, 1999·Annual Review of Immunology·S A Porcelli, R L Modlin
Mar 23, 2004·Annual Review of Immunology·Manfred Brigl, Michael B Brenner
Dec 8, 2006·Annual Review of Immunology·Albert BendelacLuc Teyton
Dec 24, 2013·Nature Immunology·Annemieke de JongD Branch Moody
Jan 15, 2004·Proceedings of the National Academy of Sciences of the United States of America·Jang-June ParkSebastian Joyce
Sep 3, 2004·Proceedings of the National Academy of Sciences of the United States of America·Ildiko Van RhijnD Branch Moody

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.